Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

NCT00876850 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Terminated

Conditions

Skin Structures and Soft Tissue Infections

Interventions

DRUG: PTK 0796
DRUG: Linezolid

Sponsor

Paratek Pharmaceuticals Inc